Randomized Controlled Trial
The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial
Affiliations
- PMID: 20214051
Item in Clipboard
Randomized Controlled Trial
The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial
Ann Ophthalmol (Skokie).
2009 Fall-Winter.
Abstract
We compared the efficacy and safety of a new fixed combination of timolol 0.5%/odorzolamide 20%/brimonidine 0.2% in ophthalmic solution versus a fixed combination of timolol 0.5%/dorzolamide 2% in patients with open-angle glaucoma or ocular hypertension. The fixed triple combination was significantly more efficient in mean intraocular pressure reduction from baseline throughout the six-month follow-up.
Similar articles
-
Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.Curr Med Res Opin. 2009 Jul;25(7):1645-53. doi: 10.1185/03007990902994041. Curr Med Res Opin. 2009. PMID: 19476406 Clinical Trial.
-
An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.J Glaucoma. 2008 Dec;17(8):674-9. doi: 10.1097/IJG.0b013e318168f008. J Glaucoma. 2008. PMID: 19092465 Clinical Trial.
-
Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.Ophthalmology. 2003 Mar;110(3):615-24. doi: 10.1016/S0161-6420(02)01900-0. Ophthalmology. 2003. PMID: 12623832 Clinical Trial.
-
[Azarga, a new and useful fixed combination in glaucoma treatment].Oftalmologia. 2011;55(3):38-46. Oftalmologia. 2011. PMID: 22428291 Review. Romanian.
-
Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.Expert Opin Pharmacother. 2010 Apr;11(6):959-68. doi: 10.1517/14656561003667540. Expert Opin Pharmacother. 2010. PMID: 20307220 Review.
Cited by
-
Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension.Clin Ophthalmol. 2012;6:1051-5. doi: 10.2147/OPTH.S33578. Epub 2012 Jul 11. Clin Ophthalmol. 2012. PMID: 22848147 Free PMC article.
-
Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.BMC Ophthalmol. 2014 Dec 19;14:161. doi: 10.1186/1471-2415-14-161. BMC Ophthalmol. 2014. PMID: 25527295 Free PMC article. Clinical Trial.
-
Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension.Clin Ophthalmol. 2010 Nov 22;4:1331-46. doi: 10.2147/OPTH.S14054. Clin Ophthalmol. 2010. PMID: 21139674 Free PMC article.
-
A 4-year retrospective study of add-on therapy to the fixed combination of dorzolamide/timolol for the treatment of POAG.Int J Ophthalmol. 2014 Apr 18;7(2):330-4. doi: 10.3980/j.issn.2222-3959.2014.02.25. eCollection 2014. Int J Ophthalmol. 2014. PMID: 24790880 Free PMC article.
-
A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma.Ophthalmol Ther. 2018 Jun;7(1):145-156. doi: 10.1007/s40123-018-0128-8. Epub 2018 Apr 21. Ophthalmol Ther. 2018. PMID: 29680880 Free PMC article.